NCT01967758 2018-08-17Phase I Study of Safety and Immunogenicity of ADU-623Providence Health & ServicesPhase 1 Completed11 enrolled
NCT00004216 2013-07-18VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TherapyNational Cancer Institute (NCI)Phase 1 Completed